GO:0016607 nuclear speck: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0016607 nuclear speck is a discrete extra-nucleolar subnuclear domain, 20-50 in number, where splicing factors localize by immunofluorescence microscopy.
• Nuclear speck assembly depends on SON and SRRM2, and SRRM2 phase separation drives formation of speckle subcompartments.
• Genome organization around nuclear speckles drives mRNA splicing efficiency, linking speckle proximity to co-transcriptional splicing.
• Nuclear speck components are mislocalized in neurodegeneration, including tau aggregate assemblies in disease.
• Nuclear speckles regulate functional programs in cancer, making them candidate therapeutic and biomarker nodes.
• Splicing regulation through biomolecular condensates and membraneless organelles is an emerging framework for understanding nuclear speck function.
Description
GO:0016607 nuclear speck is a discrete extra-nucleolar subnuclear domain, 20-50 in number, in which splicing factors are seen to be localized by immunofluorescence microscopy. Nuclear speckles are membraneless organelles that concentrate pre-mRNA splicing factors and are increasingly recognized as spatial organizers of gene expression. Their assembly requires specific protein scaffolds, and their composition is dynamic across cell states. Because nuclear speckles influence splicing efficiency and are remodeled in disease, they are a high-value compartment for functional genomics and cell-model research.
nuclear speck At A Glance
| GO ID | GO:0016607 |
|---|---|
| GO term | nuclear speck |
| Ontology | cellular_component |
| Synonym | nuclear speckle, nuclear speckles, speckle domain, speckle focus, splicing speckle |
| Major function | Localization of splicing factors and spatial organization of mRNA splicing |
| Number per nucleus | 20-50 discrete extra-nucleolar domains |
| Key assembly factors | SON and SRRM2 |
| Disease relevance | Cancer and neurodegeneration |
What Is GO:0016607?
The QuickGO definition of GO:0016607 nuclear speck is a discrete extra-nucleolar subnuclear domain, 20-50 in number, in which splicing factors are seen to be localized by immunofluorescence microscopy. In practical terms, nuclear speckles are membraneless nuclear bodies enriched in splicing factors and associated with active gene expression and RNA processing. They are distinct from other nuclear bodies such as nucleoli and are visualized as speckled patterns by immunofluorescence using splicing-factor antibodies.
Why Is nuclear speck Important in Cell Biology?
Nuclear speckles are important because they concentrate splicing factors and influence mRNA splicing efficiency through spatial genome organization. Their assembly depends on SON and SRRM2, and SRRM2 phase separation drives subcompartment formation, making them a model for biomolecular condensate biology. In disease, nuclear speck components are mislocalized in tau aggregate assemblies and nuclear speckles regulate functional programs in cancer, highlighting their translational relevance.
• Nuclear speckles concentrate splicing factors and support co-transcriptional pre-mRNA splicing.
• Genome organization around nuclear speckles drives mRNA splicing efficiency.
• SON and SRRM2 are essential for nuclear speckle formation.
• SRRM2 phase separation drives assembly of nuclear speckle subcompartments.
• Nuclear speck components are mislocalized in tau aggregate assemblies in neurodegeneration.
• Nuclear speckles regulate functional programs in cancer.
• Splicing regulation through biomolecular condensates is an emerging theme.
• Nuclear speckles are membraneless organelles amenable to live-cell imaging and perturbation.
• They provide a spatial framework linking transcription and RNA processing.
• They are candidate biomarkers and therapeutic targets in disease.
Structure and Composition of nuclear speck
Definition and visualization
In simple terms: Nuclear speckles are little speckled dots inside the nucleus that light up when you stain splicing factors.
GO:0016607 nuclear speck is defined as a discrete extra-nucleolar subnuclear domain, 20-50 in number, in which splicing factors are seen to be localized by immunofluorescence microscopy. Nuclear speckles are membraneless nuclear bodies enriched in splicing factors and are visualized as speckled patterns by immunofluorescence. They are distinct from nucleoli and other nuclear bodies and are associated with active gene expression and RNA processing.
Core protein components
In simple terms: Speckles are built from specific proteins that act like scaffolds and glue.
SON and SRRM2 are essential for nuclear speckle formation, and loss of these factors disrupts speckle integrity. SRRM2 phase separation drives assembly of nuclear speckle subcompartments, indicating that condensate formation is a core assembly mechanism. Splicing factors localize to speckles, consistent with their role in pre-mRNA processing.
Assembly and subcompartments
In simple terms: Speckles assemble in steps, with some proteins forming inner subcompartments.
Nuclear speckle assembly depends on SON and SRRM2, and SRRM2 phase separation drives assembly of nuclear speckle subcompartments. Splicing regulation through biomolecular condensates and membraneless organelles provides a framework for understanding how speckle subcompartments form and function. Genome organization around nuclear speckles drives mRNA splicing efficiency, linking speckle structure to function.
Relationship to splicing and gene expression
In simple terms: Speckles help genes and splicing machinery meet efficiently.
Genome organization around nuclear speckles drives mRNA splicing efficiency, indicating that speckle proximity to active genes supports co-transcriptional splicing. Emerging and re-emerging themes in co-transcriptional pre-mRNA splicing highlight the spatial coupling of transcription and splicing. Splicing regulation through biomolecular condensates further supports the role of speckles in organizing RNA processing.
Key Genes Involved in GO:0016607 nuclear speck
The following genes and proteins are central to nuclear speck biology based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SON | Essential for nuclear speckle formation | Speckle assembly and integrity studies |
| SRRM2 | Phase separation drives nuclear speckle subcompartments | Condensate biology and speckle assembly |
| SRRM2 | Essential for nuclear speckle formation | Speckle integrity and splicing regulation |
| SRSF proteins | Splicing factors localized to speckles | Splicing factor localization and function |
| Tau (MAPT) | Tau aggregates mislocalize nuclear speckle components | Neurodegeneration and speckle mislocalization |
| FTO | N6-methyladenosine in nuclear RNA is a major substrate | Nuclear RNA modification and speckle-related RNA processing |
| Splicing factors | Localize to nuclear speckles by immunofluorescence | Speckle visualization and quantification |
| SRRM2 | Subcompartment assembly via phase separation | Live-cell imaging of condensates |
| SON | Scaffold for speckle formation | Knockout and knockdown models |
| SRRM2 | Scaffold for speckle formation | Knockout and knockdown models |
| Tau (MAPT) | Forms RNA-protein assemblies with speckle components | Tauopathy models |
| Splicing regulators | Regulate co-transcriptional splicing | Co-transcriptional splicing assays |
| Condensate proteins | Drive membraneless organelle assembly | Biomolecular condensate research |
| Nuclear speckle components | Regulate functional programs in cancer | Cancer cell models |
| SRRM2 | Phase separation and subcompartment formation | Phase separation perturbation studies |
| SON | Essential speckle factor | Speckle assembly reconstitution |
| Splicing factors | Localize to speckles | Immunofluorescence microscopy |
How Is nuclear speck Regulated?
Nuclear speck assembly and function are regulated by the availability of core scaffold proteins SON and SRRM2, and by SRRM2 phase separation that drives subcompartment formation. Splicing regulation through biomolecular condensates and membraneless organelles provides a general framework for how speckle dynamics are controlled. Genome organization around nuclear speckles further modulates splicing efficiency, linking chromatin positioning to speckle function.
nuclear speck and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MAPT (Tau) | Tau aggregates mislocalize nuclear speckle components | Tauopathy cell models with speckle imaging |
| SRRM2 | Speckle assembly and subcompartments | SRRM2 knockout and phase-separation mutants |
| SON | Essential speckle formation | SON knockout cells with immunofluorescence |
| Splicing factors | Co-transcriptional splicing efficiency | Splicing reporter assays |
| Nuclear speckle components | Cancer functional programs | Cancer cell line panels with speckle profiling |
Neurodegeneration and tauopathies
Tau aggregates are RNA-protein assemblies that mislocalize multiple nuclear speckle components, linking nuclear speck dysfunction to neurodegeneration. This mislocalization suggests that speckle components may be sequestered into pathological assemblies in tauopathies.
Cancer
Nuclear speckles regulate functional programs in cancer, indicating that speckle composition and organization contribute to tumor cell states. This makes nuclear speck components candidate biomarkers and therapeutic targets in oncology.
RNA processing and splicing disorders
Because nuclear speckles concentrate splicing factors and support co-transcriptional splicing, disruption of speckle assembly by loss of SON or SRRM2 can impair splicing efficiency. Splicing regulation through biomolecular condensates further connects speckle dysfunction to RNA processing disorders.
From nuclear speck-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is SON required for nuclear speck formation? | SON knockout cell line |
| Does SRRM2 phase separation drive subcompartments? | SRRM2 point mutants and tagged knock-in |
| How do speckles affect splicing efficiency? | Splicing reporter with speckle imaging |
| Do tau aggregates mislocalize speckle components? | Tau overexpression and aggregate models |
| Do speckles regulate cancer programs? | Cancer cell lines with speckle perturbation |
| How do condensates regulate splicing? | Biomolecular condensate perturbation models |
How to Study the nuclear speck Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Immunofluorescence microscopy | Speckle number and splicing factor localization | Speckle visualization and quantification |
| Live-cell imaging | Phase separation and subcompartment dynamics | Condensate assembly studies |
| Splicing reporter assays | mRNA splicing efficiency | Co-transcriptional splicing analysis |
| RNA-seq | Global splicing changes | Transcriptome-wide splicing profiling |
| Proteomics | Speckle protein composition | Component identification |
| RNA modification profiling | N6-methyladenosine in nuclear RNA | Nuclear RNA modification studies |
| Perturbation screens | Functional programs regulated by speckles | Cancer and disease model screening |
Immunofluorescence microscopy
Immunofluorescence microscopy is the defining method for nuclear speck visualization, using antibodies against splicing factors to detect 20-50 discrete extra-nucleolar domains. This approach is used to assess speckle number, size, and localization in cells.
Live-cell imaging of condensates
Live-cell imaging of tagged speckle proteins such as SRRM2 allows tracking of phase separation and subcompartment assembly dynamics. This method is used to test how perturbations affect speckle formation.
Splicing efficiency assays
Splicing reporters and RNA-seq measure how genome organization around nuclear speckles drives mRNA splicing efficiency. These assays link speckle proximity to co-transcriptional splicing outcomes.
Proteomics and RNA modification profiling
Proteomic and RNA modification approaches, including studies of N6-methyladenosine in nuclear RNA, help define the molecular composition and substrates associated with nuclear speck-related RNA processing. These methods complement imaging and splicing assays.
How CRISPR Can Be Used to Study GO:0016607 nuclear speck
Knockout
CRISPR knockout of SON or SRRM2 can test whether these factors are essential for nuclear speckle formation, as supported by loss-of-function evidence. Knockout models enable immunofluorescence-based assessment of speckle integrity.
Point Mutation
Point mutations in SRRM2 can be introduced to dissect phase separation domains that drive nuclear speckle subcompartment assembly. Such mutants help separate assembly functions from other roles.
Knock-in
Tagged knock-in of SRRM2 or SON allows live-cell imaging of nuclear speck dynamics and subcompartment formation. Knock-in reporters support tracking of speckle assembly in real time.
Overexpression
Overexpression of tau or speckle components can model mislocalization of nuclear speckle components in disease contexts. Overexpression systems help test whether speckle disruption contributes to pathology.
How EDITGENE Supports nuclear speck Research
Researchers studying nuclear speck-related genes often need to determine whether a candidate gene is causally involved in speckle assembly, splicing efficiency, or disease-associated mislocalization. Rigorous causal testing requires precise genome editing and functional readouts that connect genotype to speckle phenotype.
Contact EDITGENE today to design your custom CRISPR model for nuclear speck research.
Frequently Asked Questions About nuclear speck
What is GO:0016607 nuclear speck?
GO:0016607 nuclear speck is a discrete extra-nucleolar subnuclear domain, 20-50 in number, in which splicing factors are seen to be localized by immunofluorescence microscopy.
What genes are involved in nuclear speck formation?
SON and SRRM2 are essential for nuclear speckle formation, and SRRM2 phase separation drives subcompartment assembly.
How are nuclear speckles visualized?
Nuclear speckles are visualized by immunofluorescence microscopy using antibodies against splicing factors, appearing as 20-50 discrete extra-nucleolar domains.
Do nuclear speckles affect mRNA splicing efficiency?
Yes, genome organization around nuclear speckles drives mRNA splicing efficiency, linking speckle proximity to co-transcriptional splicing.
Are nuclear speckles involved in cancer?
Nuclear speckles regulate functional programs in cancer, making them relevant to tumor cell states and potential therapeutic targeting.
Are nuclear speckles involved in neurodegeneration?
Tau aggregates are RNA-protein assemblies that mislocalize multiple nuclear speckle components, linking speckles to neurodegeneration.
What is the relationship between nuclear speckles and biomolecular condensates?
Splicing regulation through biomolecular condensates and membraneless organelles provides a framework for understanding nuclear speck assembly and function.
What proteins drive nuclear speck subcompartments?
SRRM2 phase separation drives assembly of nuclear speckle subcompartments.
How can CRISPR be used to study nuclear speckles?
CRISPR knockout of SON or SRRM2 can test essential roles in speckle formation, while point mutations and tagged knock-ins can dissect phase separation and dynamics.
What methods study nuclear speck function?
Immunofluorescence microscopy, live-cell imaging, splicing reporter assays, RNA-seq, proteomics, and RNA modification profiling are commonly used.
Conclusion
GO:0016607 nuclear speck is a discrete extra-nucleolar subnuclear domain, 20-50 in number, where splicing factors localize by immunofluorescence microscopy. Its assembly depends on SON and SRRM2, and SRRM2 phase separation drives subcompartment formation. Nuclear speckles influence mRNA splicing efficiency through spatial genome organization and are implicated in cancer and neurodegeneration. Studying nuclear speck biology with precise CRISPR models and functional assays will clarify causal mechanisms and disease relevance.
References
- 1. Jia G et al.. 2011. N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO.. Nat Chem Biol 7(12):885-7 PMID: 22002720
- 2. Bhat P et al.. 2024. Genome organization around nuclear speckles drives mRNA splicing efficiency.. Nature 629(8014):1165-1173 PMID: 38720076
- 3. Lester E et al.. 2021. Tau aggregates are RNA-protein assemblies that mislocalize multiple nuclear speckle components.. Neuron 109(10):1675-1691.e9 PMID: 33848474
- 4. Carrocci TJ et al.. 2024. Emerging and re-emerging themes in co-transcriptional pre-mRNA splicing.. Mol Cell 84(19):3656-3666 PMID: 39366353
- 5. Ilik İA et al.. 2020. SON and SRRM2 are essential for nuclear speckle formation.. Elife 9 PMID: 33095160
- 6. Zhang M et al.. 2024. SRRM2 phase separation drives assembly of nuclear speckle subcompartments.. Cell Rep 43(3):113827 PMID: 38381607
- 7. Alexander KA et al.. 2025. Nuclear speckles regulate functional programs in cancer.. Nat Cell Biol 27(2):322-335 PMID: 39747580
- 8. Giudice J et al.. 2024. Splicing regulation through biomolecular condensates and membraneless organelles.. Nat Rev Mol Cell Biol 25(9):683-700 PMID: 38773325
